XENE · NASDAQ · Biotechnology

Xenon Pharmaceuticals (XENE)

Develops azetukalner and ion-channel medicines for epilepsy, depression, and pain.

$38.88
After-hours close−0.20 (−0.50%)
At close$39.08(+0.22%)